IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, pa… Read more
IOL Chemicals and Pharmaceuticals Limited (IOLCP) - Total Liabilities
Latest total liabilities as of September 2025: ₹6.62 Billion INR
Based on the latest financial reports, IOL Chemicals and Pharmaceuticals Limited (IOLCP) has total liabilities worth ₹6.62 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
IOL Chemicals and Pharmaceuticals Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how IOL Chemicals and Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
IOL Chemicals and Pharmaceuticals Limited Competitors by Total Liabilities
The table below lists competitors of IOL Chemicals and Pharmaceuticals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kintor Pharmaceutical Limited
PINK:KNTPF
|
USA | $175.89 Million |
|
Arbor Technology
TWO:3594
|
Taiwan | NT$2.34 Billion |
|
Genovate Biotechnology Co Ltd
TWO:4130
|
Taiwan | NT$126.05 Million |
|
Aminex PLC
PINK:AEXFF
|
USA | $15.15 Million |
|
Ballard Mining Ltd
AU:BM1
|
Australia | AU$9.26 Million |
|
Gajah Tunggal Tbk
JK:GJTL
|
Indonesia | Rp12.21 Trillion |
|
ÖKOWORLD AG
XETRA:VVV3
|
Germany | €24.57 Million |
|
mPLUS Corp
KQ:259630
|
Korea | ₩149.67 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down IOL Chemicals and Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.99 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.29 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how IOL Chemicals and Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for IOL Chemicals and Pharmaceuticals Limited (2005–2025)
The table below shows the annual total liabilities of IOL Chemicals and Pharmaceuticals Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹6.94 Billion | +9.72% |
| 2024-03-31 | ₹6.33 Billion | +23.03% |
| 2023-03-31 | ₹5.14 Billion | -9.76% |
| 2022-03-31 | ₹5.70 Billion | +63.02% |
| 2021-03-31 | ₹3.50 Billion | -1.85% |
| 2020-03-31 | ₹3.56 Billion | -23.80% |
| 2019-03-31 | ₹4.68 Billion | -26.53% |
| 2018-03-31 | ₹6.36 Billion | +1.21% |
| 2017-03-31 | ₹6.29 Billion | +7.06% |
| 2016-03-31 | ₹5.87 Billion | +18.79% |
| 2015-03-31 | ₹4.94 Billion | -7.04% |
| 2014-03-31 | ₹5.32 Billion | -3.99% |
| 2013-03-31 | ₹5.54 Billion | +7.91% |
| 2012-03-31 | ₹5.13 Billion | +17.33% |
| 2011-03-31 | ₹4.38 Billion | +21.52% |
| 2010-03-31 | ₹3.60 Billion | +22.39% |
| 2009-03-31 | ₹2.94 Billion | +88.13% |
| 2008-03-31 | ₹1.56 Billion | +8.78% |
| 2007-03-31 | ₹1.44 Billion | +88.89% |
| 2006-03-31 | ₹761.01 Million | +53.56% |
| 2005-03-31 | ₹495.59 Million | -- |